New PhD Programme – Human Eye Diseases, Development, Stem Cell Biology, Neuroscience and Computer Science
UCL and Santen Pharmaceutical Co., Ltd (Santen) have established an exciting new PhD studentship scheme within the UCL SenSyT (Sensory Systems, Technologies, and Therapies) PhD Programme for vision and hearing research.
Three full time PhD studentships are available to start from October 2016. You can find the information of projects in this link. Each includes a tax free maintenance stipend of £22,278 per annum (2016/2017 rate) and tuition fees at the home/EU rate or the international rate. These studentships are funded for 3.5 years including generous research costs. The students will perform their research at the UCL Institute of Ophthalmology.
We are looking for highly motivated and talented students who have research experience in biology, medical science, or computer science. The selected students will engage in projects studying major neurodegenerative diseases of eye such as Glaucoma, Age-related Macular Degeneration, and Diabetic Retinopathy, aiming to develop new diagnostics and treatments.
- October 2016
- 1st class or upper 2nd degree in a relevant discipline
- English language requirements, IELTS 6.5 (international students)
- 7 August 2016 (Interviews in August)
How to apply:
- For enquiries or to submit an application please email (firstname.lastname@example.org).
- Applicants should submit a supporting statement including your choices of the projects, a curriculum vitae (CV), and contact details of two academic referees.
SenSyT is a multi-disciplinary research network at UCL dedicated to the study of sensory diseases, which harnesses the vast range of research disciplines, and experimental approaches. SenSyT is committed to advancing basic and translational research to tackle the scientific and biomedical challenges of human sensory health. A particular focus of these UCL-Santen studentships is given to the senses of vision. For details, please visit the SenSyT website. www.ucl.ac.uk/sensyt
UCL Institute of Ophthalmology is a world leader in studies of vision and eye disease. The institute has around 45 principal investigators and cooperates closely with Moorfields Eye Hospital. The Institute is the oldest and largest centre for ophthalmic treatment, teaching and research in the world.
Santen Pharmaceutical Co., Ltd. is a specially dedicated company in the ophthalmic field. Santen is strong committed to innovative research and one of the leading ophthalmic companies worldwide.